Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2018

Miyazawa M, Subbaramaiah K, Bhardwaj P, Zhou XK, Wang H, Falcone DJ, et al. Pioglitazone Inhibits Periprostatic White Adipose Tissue Inflammation in Obese Mice. Cancer Prev Res (Phila). 2018;11(4):215-226.

Gold SL, Magro C, Scherl E. A Unique Infusion Reaction to Vedolizumab in a Patient With Crohn's Disease. Gastroenterology. 2018;155(4):981-982.

Graff RE, Ahearn TU, Pettersson A, Ebot EM, Gerke T, Penney KL, et al. Height, Obesity, and the Risk of -Defined Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2018;27(2):193-200.

Debnath S, Yallowitz AR, McCormick J, Lalani S, Zhang T, Xu R, et al. Discovery of a periosteal stem cell mediating intramembranous bone formation. Nature. 2018;562(7725):133-139.

DeSimone RA, Leung WK, Schwartz J. Transfusion Medicine in a Multidisciplinary Approach to Morbidly Adherent Placenta: Preparing for and Preventing the Worst. Transfus Med Rev. 2018;32(4):244-248.

Haffner MC, Taheri D, Luidy-Imada E, Palsgrove DN, Eich M-, Netto GJ, et al. Hypomethylation, endogenous retrovirus expression, and interferon signaling in testicular germ cell tumors. Proc Natl Acad Sci U S A. 2018;115(37):E8580-E8582.

Jacobs SE, Zhong E, Hartono C, Satlin MJ, Magro CM, Jenkins SG, et al. Closing the Brief Case: Disseminated Mycobacterium haemophilum Infection in a Kidney Transplant Recipient. J Clin Microbiol. 2018;56(1).

Trindade AJ, Benias PC, Inamdar S, Fan C, Sethi A, Fukami N, et al. Use of volumetric laser endomicroscopy for determining candidates for endoscopic therapy in superficial esophageal squamous cell carcinoma. United European Gastroenterol J. 2018;6(6):838-845.

Moore MD, Postma E, Gray KD, Ullmann TM, Hurley JR, Goldsmith S, et al. Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma. World J Surg. 2018;42(2):343-349.

Ravi R, Noonan KA, Pham V, Bedi R, Zhavoronkov A, Ozerov IV, et al. Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nat Commun. 2018;9(1):741.